FDA Inspection 1204434 — Pfizer, Inc.

Pfizer, Inc. — FEI 1211022

The FDA completed an inspection of Pfizer, Inc. on Apr 19, 2023 in Groton, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Groton, CT (United States)

Additional details

Sponsor, Contract Research Organization

Need the full FDA record for Pfizer, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.